PMC:7289100 / 3151-3228 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":43,"end":47},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"n leukemia patients receiving engineered T cell therapy. These cases with Cov"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T46","span":{"begin":2,"end":10},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"}],"text":"n leukemia patients receiving engineered T cell therapy. These cases with Cov"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T34","span":{"begin":41,"end":47},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"n leukemia patients receiving engineered T cell therapy. These cases with Cov"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T27","span":{"begin":2,"end":10},"obj":"Phenotype"}],"attributes":[{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0001909"}],"text":"n leukemia patients receiving engineered T cell therapy. These cases with Cov"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T62","span":{"begin":41,"end":47},"obj":"CL:0000084"},{"id":"T74273","span":{"begin":41,"end":47},"obj":"CL:0000084"}],"text":"n leukemia patients receiving engineered T cell therapy. These cases with Cov"}

{"project":"LitCovid-PubTator","denotations":[{"id":"85","span":{"begin":11,"end":19},"obj":"Species"},{"id":"106","span":{"begin":2,"end":10},"obj":"Disease"}],"attributes":[{"id":"A85","pred":"tao:has_database_id","subj":"85","obj":"Tax:9606"},{"id":"A106","pred":"tao:has_database_id","subj":"106","obj":"MESH:D007938"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n leukemia patients receiving engineered T cell therapy. These cases with Cov"}